Crossmark

Clinical MRI-radiomics model based on support vector machine to predict the efficacy of first transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1007/s11547-025-02141-5

Published Online: 2025-11-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Ze

Xu, Anhui

Zhang, Yi

Jiang, Nan

Hao, Yonghong

Zhou, Ruibing

Mu, Ketao

Yin, Xiaoxv https://orcid.org/0000-0002-5020-2984
Funding

Funding for this research was provided by:

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China (81901713)
License Information

Text and Data Mining valid from 2025-11-08

Version of Record valid from 2025-11-08
More Information

Article History

Received: 29 March 2025

Accepted: 22 October 2025

First Online: 8 November 2025

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: This study was approved by the institutional review board of Tongji Hospital, Huazhong University of Science and Technology, which complied with the standards of the Declaration of Helsinki.

: The requirement of written informed consent was waived for the retrospective nature.

: No applicable.

Document is current

Any future updates will be listed below